Compare NAN & USNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NAN | USNA |
|---|---|---|
| Founded | 1999 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 357.9M | 362.9M |
| IPO Year | N/A | 1996 |
| Metric | NAN | USNA |
|---|---|---|
| Price | $11.54 | $19.87 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $36.00 |
| AVG Volume (30 Days) | 74.6K | ★ 186.7K |
| Earning Date | 01-01-0001 | 10-22-2025 |
| Dividend Yield | ★ 4.37% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.90 |
| Revenue | N/A | ★ $912,670,000.00 |
| Revenue This Year | N/A | $9.87 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $21.96 |
| Revenue Growth | N/A | ★ 5.88 |
| 52 Week Low | $9.11 | $18.48 |
| 52 Week High | $11.34 | $38.85 |
| Indicator | NAN | USNA |
|---|---|---|
| Relative Strength Index (RSI) | 49.34 | 45.49 |
| Support Level | $11.50 | $19.49 |
| Resistance Level | $11.65 | $20.40 |
| Average True Range (ATR) | 0.07 | 0.55 |
| MACD | -0.00 | 0.25 |
| Stochastic Oscillator | 40.00 | 67.36 |
Nuveen New York Quality Municipal Income Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal, New York State and New York City income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.